Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 6176 - 6200 of 6844 in total

Frankincense

Experimental

3-[[(3R,4S,5S,6R)-7-Benzyl-4,5-dihydroxy-1,1-dioxo-3,6-bis(phenoxymethyl)-1,2,7-thiadiazepan-2-yl]methyl]-N-methylbenzamide

Experimental

{4-[(2S)-2-Acetamido-3-({(1S)-1-[3-carbamoyl-4-(cyclohexylmethoxy)phenyl]ethyl}amino)-3-oxopropyl]-2-phosphonophenoxy}acetic acid

Experimental

ABT-341

ABT-341 is a potent and selective DPP-4 inhibitor with a structure very similar to sitagliptin (in 2D; the 3D structure is significantly different).
Experimental

Magnesium aspartate

Magnesium aspartate is a magnesium salt of aspartic acid that is commonly used as a mineral supplement. It displays high oral bioavailability and water solubiltiy compared to other magnesium salts such as magnesium citrate, magnesium carbonate and magnesium oxide.
Experimental

Cyclomethicone

Experimental

Nardostachys chinensis whole

Nardostachys chinensis whole is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Experimental

Cinchonidine

Investigational

Mivavotinib

Investigational

Nutlin-3

Nutlin-3 is a small molecule inhibitor that targets p53-Mdm2 interaction.
Investigational

AGT-182

AGT-182 is an investigational enzyme replacement therapy engineered by the fusion of the iduronate-2-sulfatase (IDS) enzyme and a human insulin receptor monoclonal antibody.
Investigational

Golcadomide

Investigational

(2r,4s)-2-Methyl-2,3,3,4-Tetrahydroxytetrahydrofuran

Experimental

(3R)-3-ethyl-N-[(4-methylphenyl)sulfonyl]-L-aspartic acid

Experimental

5-BROMO-2-{[(4-CHLOROPHENYL)SULFONYL]AMINO}BENZOIC ACID

Experimental

N-{[6-(PENTYLOXY)NAPHTHALEN-2-YL]SULFONYL}-D-GLUTAMIC ACID

Experimental

Dapirolizumab pegol

Dapirolizumab pegol is under investigation in clinical trial NCT02804763 (A Phase 2 Efficacy and Safety Study of Dapirolizumab Pegol (DZP) in Systemic Lupus Erythematosus).
Investigational

Pemrametostat

Pemrametostat is under investigation in clinical trial NCT03614728 (Study to Investigate the Safety and Clinical Activity of GSK3326595 and Other Agents to Treat Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)).
Investigational

2,4-deoxy-4-guanidino-5-N-acetyl-neuraminic acid

Experimental

N-Formylmethionine

N-Formylmethionine is effective in the initiation of protein synthesis. The initiating methionine residue enters the ribosome as N-formylmethionyl tRNA. This process occurs in Escherichia coli and other bacteria as well as in the mitochondria of eucaryotic cells.
Experimental

Vitespen

Investigational

Tomivosertib

Tomivosertib is under investigation in clinical trial NCT03318562 (A PD Study of Oral eFT508 in Subjects With Advanced TNBC and HCC).
Investigational

Glumetinib

Glumetinib is under investigation in clinical trial NCT04270591 (Assess the Anti-tumor Activity and Safety of Glumetinib in Patient With Advanced C-met-positive Non-small Cell Lung Cancer).
Investigational

AGIL-FA

Investigational

pM-81

Investigational
Displaying drugs 6176 - 6200 of 6844 in total